We work together with stakeholders to inform policies that improve treatment and care for people with diabetes, haemophilia and growth disorders.
We advocate for equal rights, affordability and accessibility to healthcare for all as stated in the United Nations Universal Declaration of Human Rights
We apply global ethical principles and proper scientific methods, as well as adhering to global and local regulatory requirements in all our clinical research activities.
The Novo Nordisk business is based on a clear vision, a strong set of core values and a consistent corporate governance model.
As a natural consequence, we have formulated positions on issues of relevance to our business and our role as a global corporate citizen.